Pharmacological characterization of nanoparticle-induced platelet microaggregation using quartz crystal microbalance with dissipation: comparison with light aggregometry

References

• ParveenSMisraRSahooSKNanoparticles: a boon to drug delivery, therapeutics, diagnostics and imagingNanomedicine20128214716621703993
   PubMed Web of Science ®Google Scholar
• KhanIUSerraCAAntonNVandammeTFProduction of nanoparticle drug delivery systems with microfluidics toolsExpert Opin Drug Deliv201512454756225345543
   PubMed Web of Science ®Google Scholar
• DavìGPatronoCPlatelet activation and atherothrombosisN Engl J Med2007357242482249418077812
   PubMed Web of Science ®Google Scholar
• LindenMDJacksonDEPlatelets: pleiotropic roles in atherogenesis and atherothrombosisInt J Biochem Cell Biol201042111762176620673808
   PubMed Web of Science ®Google Scholar
• RuggeriZMPlatelets in atherothrombosisNat Med20028111227123412411949
   PubMed Web of Science ®Google Scholar
• Antithrombotic Trialists’ CollaborationCollaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ20023247329718611786451
   PubMed Web of Science ®Google Scholar
• MareeAOFitzgeraldDJVariable platelet response to aspirin and clopidogrel in atherothrombotic diseaseCirculation2007115162196220717452618
   PubMed Web of Science ®Google Scholar
• RadomskiAJuraszPAlonso-EscolanoDNanoparticle-induced platelet aggregation and vascular thrombosisBr J Pharmacol2005146688289316158070
   PubMed Web of Science ®Google Scholar
• CorbalanJJMedinaCJacobyAMalinskiTRadomskiMWAmorphous silica nanoparticles aggregate human platelets: potential implications for vascular homeostasisInt J Nanomedicine2012763163922334785
   PubMed Web of Science ®Google Scholar
• TomaszewskiKARadomskiMWSantos-MartinezMJNanodiagnostics, nanopharmacology and nanotoxicology of platelet-vessel wall interactionsNanomedicine (Lond)20151091451147525996119
   PubMed Web of Science ®Google Scholar
• MedinaCSantos-MartinezMJRadomskiACorriganOIRadomskiMWNanoparticles: pharmacological and toxicological significanceBr J Pharmacol2007150555255817245366
   PubMed Web of Science ®Google Scholar
• Santos-MartinezMJA novel method for the measurement of flow-induced platelet activation at nanoscale resolution levelPhD thesisDublin, IrelandTrinity College Dublin2009
   Google Scholar
• Santos-MartínezMJMedinaCPrina-MelloAA nanoscale resolution assay of flow-induced platelet microaggregationKardiochir Torakochi201074365375
   Web of Science ®Google Scholar
• Santos-MartinezMJRahmeKCorbalanJJPegylation increases platelet biocompatibility of gold nanoparticlesJ Biomed Nanotechnol20141061004101524749395
   PubMed Web of Science ®Google Scholar
• Santos-MartinezMJInkielewicz-StepniakIMedinaCThe use of quartz crystal microbalance with dissipation (QCM-D) for studying nanoparticle-induced platelet aggregationInt J Nanomedicine2012724325522275839
   PubMed Web of Science ®Google Scholar
• LordkipanidzéMPharandCSchampaertETurgeonJPalisaitisDADiodatiJGA comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery diseaseEur Heart J200728141702170817569678
   PubMed Web of Science ®Google Scholar
• RadomskiMMoncadaSAn improved method for washing of human platelets with prostacyclinThromb Res19833043833896351341
   PubMed Web of Science ®Google Scholar
• MedinaCJuraszPSantos-MartinezMJPlatelet aggregation-induced by Caco-2 cells: regulation by matrix metalloproteinase-2 and adenosine diphosphateJ Pharmacol Exp Ther2006317273974516424148
   PubMed Web of Science ®Google Scholar
• Alonso-EscolanoDStronginAYChungAWDeryuginaEIRadomskiMWMembrane type-1 matrix metalloproteinase stimulates tumour cell-induced platelet aggregation: role of receptor glycoproteinsBr J Pharmacol2004141224125214691052
   PubMed Web of Science ®Google Scholar
• JuraszPSawickiGDuszykMMatrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxideCancer Res200161137638211196190
   PubMed Web of Science ®Google Scholar
• RothGJMajerusPWThe mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction proteinJ Clin Invest19755636246321159076
   PubMed Web of Science ®Google Scholar
• VaneJInhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugsNat New Biol1971231252322355284360
   PubMedGoogle Scholar
• SawickiGSalasEMuratJMiszta-LaneHRadomskiMWRelease of gelatinase A during platelet activation mediates aggregationNature199738666256166199121586
   PubMed Web of Science ®Google Scholar
• Santos-MartinezMJMedinaCJuraszPRadomskiMWRole of metalloproteinases in platelet functionThromb Res2008121453554217681591
   PubMed Web of Science ®Google Scholar
• CohnMMeekGAThe mechanism of hydrolysis of adenosine di- and tri-phosphate catalysed by potato apyraseBiochem J195766112813013426119
   PubMed Web of Science ®Google Scholar
• RadomskiMWPalmerRMMoncadaSEndogenous nitric oxide inhibits human platelet adhesion to vascular endotheliumLancet198728567105710582889967
   PubMed Web of Science ®Google Scholar
• RadomskiMWPalmerRMMoncadaSComparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in plateletsBr J Pharmacol19879211811873311265
   PubMed Web of Science ®Google Scholar
• RadomskiMWPalmerRMMoncadaSAn L-arginine/nitric oxide pathway present in human platelets regulates aggregationProc Natl Acad Sci U S A19908713519351971695013
   PubMed Web of Science ®Google Scholar
• SalasEMoroMAAskewSComparative pharmacology of analogues of S-nitroso-N-acetyl-DL-penicillamine on human plateletsBr J Pharmacol19941124107110767524991
   PubMed Web of Science ®Google Scholar
• RadomskiMWReesDDDutraAMoncadaSS-nitroso-glutathione inhibits platelet activation in vitro and in vivoBr J Pharmacol199210737457491335336
   PubMed Web of Science ®Google Scholar
• RadomskiMWPalmerRMMoncadaSThe anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxideBr J Pharmacol19879236396463322462
   PubMed Web of Science ®Google Scholar
• MoncadaSGryglewskiRJBuntingJVaneJRAn enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature19762635579663665802670
   PubMed Web of Science ®Google Scholar
• NemmarAHoetPHVanquickenborneBPassage of inhaled particles into the blood circulation in humansCirculation2002105441141411815420
   PubMed Web of Science ®Google Scholar
• NemmarAHoylaertsMFHoetPHNemeryBPossible mechanisms of the cardiovascular effects of inhaled particles: systemic translocation and prothrombotic effectsToxicol Lett20041491–324325315093270
   PubMed Web of Science ®Google Scholar
• Santos-MartinezMPrina-MelloAMedinaCRadomskiMAnalysis of platelet function: role of microfluidics and nanodevicesAnalyst2011136245120512622029043
   PubMed Web of Science ®Google Scholar
• ChungAWRadomskiAAlonso-EscolanoDPlatelet-leukocyte aggregation induced by PAR agonists: regulation by nitric oxide and matrix metalloproteinasesBr J Pharmacol2004143784585515533889
   PubMed Web of Science ®Google Scholar
• SlowingIIVivero-EscotoJLWuC-WLinVSMesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriersAdv Drug Deliv Rev200860111278128818514969
   PubMed Web of Science ®Google Scholar
• YoussefAMKamelSEl-SamahyMAMorphological and antibacterial properties of modified paper by PS nanocomposites for packaging applicationsCarbohydr Polym20139811166117223987459
   PubMed Web of Science ®Google Scholar
• GligaASkoglundSOdnevall WallinderIFadeelBKarlssonHSize-dependent cytotoxicity of silver nanoparticles in human lung cells: the role of cellular uptake, agglomeration and Ag releasePart Fibre Toxicol20141111124529161
   PubMed Web of Science ®Google Scholar
• ParkE-JChoiJParkY-KParkKOxidative stress induced by cerium oxide nanoparticles in cultured BEAS-2B cellsToxicology20082451–29010018243471
   PubMed Web of Science ®Google Scholar
• LesniakASalvatiASantos-MartinezMJRadomskiMWDawsonKAÅbergCNanoparticle adhesion to the cell membrane and its effect on nanoparticle uptake efficiencyJ Am Chem Soc201313541438144423301582
   PubMed Web of Science ®Google Scholar
• MoroMARusselRJCellekScGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclaseProc Natl Acad Sci U S A1996934148014858643658
   PubMed Web of Science ®Google Scholar
• EgashiraKClinical importance of endothelial function in arteriosclerosis and ischemic heart diseaseCirc J200266652953312074266
   PubMed Web of Science ®Google Scholar
• HennekensCHDalenJEAspirin in the treatment and prevention of cardiovascular disease: past and current perspectives and future directionsAm J Med2013126537337823499330
   PubMed Web of Science ®Google Scholar
• MiyamotoSKawanoHSakamotoTFormation of platelet microaggregates correlates with adverse clinical outcome in patients with coronary artery diseaseThromb Haemost200389468168612669123
   PubMed Web of Science ®Google Scholar